Total Payments
$27,992
2024 Payments
$15,985
Companies
12
Transactions
67
Medicare Patients
1,004
Medicare Billing
$211,954
Payment Breakdown by Category
Consulting$12,296 (43.9%)
Other$10,463 (37.4%)
Travel$3,530 (12.6%)
Food & Beverage$1,703 (6.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $12,296 | 6 | 43.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,088 | 5 | 25.3% |
| Travel and Lodging | $3,530 | 10 | 12.6% |
| Honoraria | $3,375 | 3 | 12.1% |
| Food and Beverage | $1,703 | 43 | 6.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $22,716 | 27 | $0 (2024) |
| Travere Therapeutics, Inc. | $3,637 | 11 | $0 (2024) |
| AstraZeneca AB | $730.85 | 5 | $0 (2017) |
| Otsuka America Pharmaceutical, Inc. | $246.02 | 5 | $0 (2019) |
| Aurinia Pharma U.S., Inc. | $245.74 | 9 | $0 (2024) |
| NxStage Medical, Inc. | $145.32 | 2 | $0 (2018) |
| GlaxoSmithKline, LLC. | $124.99 | 1 | $0 (2023) |
| Fresenius USA Marketing, Inc. | $62.96 | 2 | $0 (2019) |
| Relypsa, Inc. | $31.29 | 2 | $0 (2017) |
| Alexion Pharmaceuticals, Inc. | $23.73 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15,985 | 23 | Amgen Inc. ($15,780) |
| 2023 | $5,681 | 17 | Amgen Inc. ($3,478) |
| 2022 | $3,551 | 8 | Amgen Inc. ($3,413) |
| 2021 | $12.99 | 1 | Vifor Pharma, Inc. ($12.99) |
| 2020 | $1,500 | 1 | Travere Therapeutics, Inc. ($1,500) |
| 2019 | $24.48 | 2 | Fresenius USA Marketing, Inc. ($12.67) |
| 2018 | $293.20 | 6 | Otsuka America Pharmaceutical, Inc. ($124.41) |
| 2017 | $943.76 | 9 | AstraZeneca AB ($730.85) |
All Payment Transactions
67 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Amgen Inc. | TAVNEOS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,350.00 | General |
| Category: Inflammation | ||||||
| 10/25/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $49.45 | General |
| Category: Inflammation | ||||||
| 10/24/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $66.76 | General |
| 10/16/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/04/2024 | Amgen Inc. | TAVNEOS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: Inflammation | ||||||
| 10/04/2024 | Amgen Inc. | TAVNEOS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: Inflammation | ||||||
| 09/25/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Inflammation | ||||||
| 09/25/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $0.42 | General |
| Category: Inflammation | ||||||
| 09/07/2024 | Amgen Inc. | TAVNEOS (Drug) | Travel and Lodging | In-kind items and services | $226.76 | General |
| Category: Inflammation | ||||||
| 09/05/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Rare Disease | ||||||
| 08/23/2024 | Amgen Inc. | TAVNEOS (Drug) | Travel and Lodging | In-kind items and services | $466.60 | General |
| Category: Inflammation | ||||||
| 08/16/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $8.61 | General |
| Category: Inflammation | ||||||
| 08/14/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 05/22/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 05/16/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $9.55 | General |
| Category: Inflammation | ||||||
| 05/10/2024 | Amgen Inc. | TAVNEOS (Drug) | Consulting Fee | Cash or cash equivalent | $5,898.75 | General |
| Category: Inflammation | ||||||
| 05/10/2024 | Amgen Inc. | TAVNEOS (Drug) | Consulting Fee | Cash or cash equivalent | $2,681.25 | General |
| Category: Inflammation | ||||||
| 04/24/2024 | Amgen Inc. | TAVNEOS (Drug) | Travel and Lodging | In-kind items and services | $408.30 | General |
| Category: Inflammation | ||||||
| 04/24/2024 | Amgen Inc. | TAVNEOS (Drug) | Travel and Lodging | In-kind items and services | $149.96 | General |
| Category: Inflammation | ||||||
| 04/02/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 02/28/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 01/25/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 01/18/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Inflammation | ||||||
| 12/29/2023 | Amgen Inc. | TAVNEOS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $450.00 | General |
| Category: Inflammation | ||||||
| 10/21/2023 | Travere Therapeutics, Inc. | — | Travel and Lodging | In-kind items and services | $449.95 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 147 | 301 | $172,268 | $28,594 |
| 2022 | 7 | 205 | 356 | $168,891 | $30,942 |
| 2021 | 9 | 364 | 768 | $506,494 | $85,766 |
| 2020 | 8 | 288 | 607 | $408,157 | $66,652 |
Total Patients
1,004
Total Services
2,032
Medicare Billing
$211,954
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 11 | 48 | $106,176 | $8,424 | 7.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 45 | 111 | $22,200 | $7,170 | 32.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 42 | 69 | $19,527 | $6,527 | 33.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 43 | $13,631 | $4,137 | 30.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $4,308 | $1,283 | 29.8% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 12 | 18 | $6,426 | $1,054 | 16.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 61 | 145 | $41,035 | $11,721 | 28.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 19 | 36 | $79,632 | $6,051 | 7.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 55 | $17,435 | $5,369 | 30.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 42 | 65 | $13,000 | $3,647 | 28.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 15 | 15 | $5,385 | $1,637 | 30.4% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 23 | 26 | $9,282 | $1,495 | 16.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 14 | $3,122 | $1,022 | 32.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 115 | 311 | $88,013 | $25,982 | 29.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 51 | 133 | $294,196 | $23,950 | 8.1% |
| 90966 | Home dialysis services per month, patient 20 years of age or older | Office | 2021 | 11 | 63 | $51,534 | $15,459 | 30.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 67 | 110 | $22,000 | $6,492 | 29.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 25 | 44 | $13,948 | $4,658 | 33.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 36 | 36 | $12,924 | $3,908 | 30.2% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 29 | 41 | $14,637 | $2,469 | 16.9% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 19 | 19 | $5,073 | $1,465 | 28.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $4,169 | $1,383 | 33.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 37 | 106 | $234,472 | $19,218 | 8.2% |
| 90966 | Home dialysis services per month, patient 20 years of age or older | Office | 2020 | 11 | 82 | $67,076 | $16,106 | 24.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 59 | 137 | $38,771 | $11,910 | 30.7% |
About Dr. Dia Waguespack, M.D
Dr. Dia Waguespack, M.D is a Internal Medicine healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2010. The National Provider Identifier (NPI) number assigned to this provider is 1932425006.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dia Waguespack, M.D has received a total of $27,992 in payments from pharmaceutical and medical device companies, with $15,985 received in 2024. These payments were reported across 67 transactions from 12 companies. The most common payment nature is "Consulting Fee" ($12,296).
As a Medicare-enrolled provider, Waguespack has provided services to 1,004 Medicare beneficiaries, totaling 2,032 services with total Medicare billing of $211,954. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology
- Location Houston, TX
- Active Since 04/14/2010
- Last Updated 02/11/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1932425006
Products in Payments
- TAVNEOS (Drug) $18,509
- Tavneos (Drug) $3,375
- FARXIGA (Drug) $730.85
- LUPKYNIS (Drug) $245.74
- SAMSCA (Drug) $130.46
- BENLYSTA (Biological) $124.99
- JYNARQUE (Drug) $115.56
- Cartridges (Device) $73.50
- System One (Device) $71.82
- Velphoro (Drug) $50.29
- XGEVA (Biological) $45.00
- Veltassa (Drug) $44.28
- ULTOMIRIS (Biological) $23.73
- KRYSTEXXA (Biological) $15.32
- 2008 Machines (Device) $12.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Houston
Stephen Pappas, M.d, M.D
Internal Medicine — Payments: $1.6M
Internal Medicine $1.6M
Mohamed Othman, Md, MD
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M
Dr. Aung Naing, Md, MD
Internal Medicine — Payments: $925,146
Internal Medicine $925,146
Miguel Escobar, M.d, M.D
Internal Medicine — Payments: $924,228
Internal Medicine $924,228
Dr. Christie Ballantyne, Md, MD
Internal Medicine — Payments: $815,154
Internal Medicine $815,154
John Heymach, M.d, M.D
Internal Medicine — Payments: $786,947
Internal Medicine $786,947